VBACs are uncommon but far from rare. In the United States, roughly 13 to 14 percent of women with a prior cesarean delivery attempt a trial of labor after cesarean (TOLAC) in a given year, and about 1.5 percent of all births are vaginal births after cesarean (VBAC). Among women who do attempt TOLAC, roughly 60 to 80 percent succeed, depending on their individual risk profile. In other words, most women who try for a VBAC achieve one, but few eligible women in the U.S. actually try.

What VBAC and TOLAC actually mean

The terminology matters because the statistics are often conflated. TOLAC is the attempt: a planned trial of labor in a woman with a prior cesarean. VBAC is the outcome: a vaginal delivery after that prior cesarean. A woman who plans a TOLAC but ends in a repeat cesarean counts in the TOLAC denominator but not the VBAC numerator.

This distinction explains the wide gap between "how many women try" and "how many succeed." National rates of VBAC as a share of all births sit near 1.5 percent, while TOLAC attempts run closer to 13 to 14 percent of eligible women. The success rate among attempters is the number most relevant to counseling, and it varies by history, hospital, and prior incision type.

The uterine scar is the central mechanism. A prior cesarean leaves a scar in the lower uterine segment, the thinned region that stretches during labor. Whether that scar holds under contraction stress determines the safety and feasibility of TOLAC. Scar integrity, not willpower or pain tolerance, is the physiologic bottleneck.

Why the scar drives the whole calculation

During a contraction, the uterine muscle shortens and the lower segment thins and pulls upward. A well-healed low-transverse scar tolerates this deformation because it sits in tissue engineered to stretch. A classical (vertical) scar or a T-incision scar sits in the contractile upper segment, which thickens rather than thins, and those scars rupture far more often.

The rupture risk is the number that shapes every guideline. For a low-transverse incision, the risk of uterine rupture during TOLAC is roughly 0.5 to 0.7 percent, or about 1 in 200. For a classical or T-incision, the risk climbs to 4 to 9 percent, which is why most guidelines advise against TOLAC after those incisions entirely.

A ruptured uterus is an obstetric emergency. It can cause fetal hypoxia, maternal hemorrhage, and, rarely, death. This is why TOLAC requires continuous fetal monitoring and immediate access to an operating room. The 1-in-200 figure is small but not negligible, and it is the reason hospitals without 24-hour surgical capability often decline to offer TOLAC.

A counterintuitive detail: a prior VBAC is the single strongest predictor of a subsequent VBAC. A woman with one successful VBAC has success rates above 85 to 90 percent on her next attempt, higher than most first-time attempters. Success tends to reproduce itself.

Quantified context: the numbers by history

Success rates are not a single statistic; they are a distribution shaped by prior obstetric history. The table below summarizes the ranges most commonly cited in obstetric guidance and cohort studies.

Prior history Approximate TOLAC success rate Approximate uterine rupture risk (low-transverse)
One prior low-transverse cesarean, no prior vaginal birth 60–70% 0.5–0.7%
One prior low-transverse cesarean plus one prior vaginal birth 75–85% 0.5–0.7%
Prior VBAC 85–90%+ 0.5–0.7%
Two prior low-transverse cesareans 60–75% (selected candidates) Slightly elevated, ~0.7–1.5%
Classical or T-incision Generally not recommended 4–9%

These are population ranges, not individual predictions. A given woman's odds depend on her interdelivery interval, the reason for her prior cesarean, her body mass index, whether labor was induced, and the baby's estimated size.

Induction matters more than many people realize. Spontaneous labor carries higher TOLAC success than induced labor, and induction with certain agents raises rupture risk. Prostaglandin agents, particularly misoprostol, are generally avoided in women with prior cesarean because they increase rupture risk. Mechanical methods such as a Foley balloon are often preferred when induction is necessary.

The interdelivery interval is another lever. An interval shorter than about 18 to 24 months is associated with modestly higher rupture risk, though the absolute increase is small. This is one reason counseling is individualized rather than formulaic.

Where the edge cases live

The cleanest candidates are women with one prior low-transverse cesarean, a spontaneous labor, a prior vaginal birth, and a normal-weight fetus. Outcomes degrade at the margins: multiple prior cesareans, unknown incision type, twins, suspected macrosomia, and induction all shift the calculus.

Twins are no longer an automatic exclusion. Selected twin pregnancies with a low-transverse scar can attempt TOLAC with success rates comparable to singletons in some series, though evidence is thinner and counseling is more cautious.

Unknown scar type is a common real-world problem. Women who had a cesarean in another country or decades ago may not have operative records. Without documentation, many clinicians assume a low-transverse incision was used, since it is by far the most common, but the assumption carries uncertainty.

A professional caveat that gets lost in consumer summaries: hospital-level factors change outcomes as much as patient factors. A hospital with a high VBAC rate and immediate surgical backup provides a different risk environment than a facility that rarely does TOLAC. The same woman can face materially different odds depending on where she delivers.

The misconceptions worth correcting

The most persistent myth is that "once a cesarean, always a cesarean." That adage is decades out of date. TOLAC is a guideline-endorsed option for most women with one prior low-transverse cesarean, and major obstetric societies support offering it.

Another misconception is that VBAC is inherently more dangerous than repeat cesarean. The comparison is not risk-free on either side. Repeat cesarean carries its own risks: placenta accreta spectrum, which rises sharply with each prior cesarean, surgical complications, and longer recovery. The two paths trade different risks rather than one being uniformly safer.

People also conflate the success rate with the attempt rate. Hearing that "VBACs are rare" often reflects low TOLAC uptake, not low success. In the U.S., the VBAC rate fell sharply after the 1990s, bottoming out around 8 to 9 percent of eligible women, then partially recovered. The decline tracked hospital policy and liability concerns more than changes in medical evidence.

A subtler misconception: a failed TOLAC is not a failure of the woman. It is a clinical outcome, often unpredictable, and it does not preclude future options.

What actually moves the odds

For a woman considering TOLAC, several concrete factors are modifiable or at least assessable in advance.

Confirm the prior incision type from operative records before planning; do not rely on memory. Ask the delivering hospital for its VBAC rate, TOLAC policy, and whether 24-hour anesthesia and surgical backup are available. Discuss induction strategy in advance; mechanical ripening is generally preferred over prostaglandins with a prior scar. Plan for continuous fetal monitoring during labor, which is standard for TOLAC. Discuss the interdelivery interval and weight trajectory with the clinician, since both modestly affect success. Have an explicit plan for what happens if labor stalls or fetal tracing becomes concerning.

Red-flag warnings that should prompt immediate contact with a clinician during a TOLAC labor:

Sudden severe abdominal pain, especially between contractions. Loss of fetal movement or an abnormal fetal heart tracing. Vaginal bleeding beyond normal bloody show. Dizziness, racing heart, or signs of shock. Contractions that stop abruptly after being strong.

These can signal uterine rupture, which requires immediate surgical response. The absolute risk is low, but the warning signs are not subtle and should never be dismissed.

Timeline: what the TOLAC decision looks like

Timing shapes both the decision and the counseling. The table below traces the typical sequence from prior birth to delivery.

Stage Approximate timing What happens
Prior cesarean Index birth Incision type documented in operative note
Interpregnancy interval 18–24+ months recommended before next conception Modestly lowers rupture risk
Prenatal counseling First trimester onward Review records, assess candidacy, discuss hospital policy
Antenatal planning Third trimester Confirm fetal position, estimate weight, plan induction approach if needed
Labor admission Onset of labor or scheduled induction Continuous fetal monitoring begins
Decision point If labor stalls or tracing abnormal Repeat cesarean vs. continued trial

The final decision point is not a failure state; it is built into the plan. Roughly 20 to 40 percent of TOLAC attempts end in repeat cesarean, and that pathway should be planned for from the start.

Limits of what the numbers can tell you

Every statistic here is a population average, and individual risk can differ substantially. The 0.5 to 0.7 percent rupture figure comes from cohorts with documented low-transverse scars and modern monitoring; it may not apply to a woman with an undocumented scar or a facility without immediate surgical backup.

The success-rate ranges also blend different definitions and eras. Some series count only spontaneous labor; others include induction. Some exclude women with prior vaginal births; others do not. Comparing numbers across sources without checking the denominators is a common source of confusion.

Guidelines themselves differ at the margins. Major obstetric bodies converge on supporting TOLAC for one prior low-transverse cesarean, but they diverge on multiple prior cesareans, twins, and induction agents. Where guidance is not uniform, the honest answer is that the evidence is thinner, not that one policy is clearly correct.

What can be said with confidence: VBAC is uncommon in practice, most attempts succeed, and the safety profile depends heavily on scar type and hospital capability. The decision is a risk trade, not a risk elimination, and it belongs in a detailed conversation with an obstetric clinician who knows the local resources.